MedPath

新华制药(高密)有限公司

Ownership
-
Established
2000-12-29
Employees
-
Market Cap
-
Website
http://www.xinhuagaomi.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

27

NMPA:27

Drug Approvals

Ibuprofen Suspension

Product Name
布洛芬混悬液
Approval Number
国药准字H20233008
Approval Date
Jan 3, 2023
NMPA

Mezlocillin Sodium for Injection

Product Name
注射用美洛西林钠
Approval Number
国药准字H20040424
Approval Date
Feb 20, 2021
NMPA

Mezlocillin Sodium for Injection

Product Name
注射用美洛西林钠
Approval Number
国药准字H20040423
Approval Date
Feb 20, 2021
NMPA

Ticarcillin Disodium

Product Name
替卡西林钠
Approval Number
国药准字H20052672
Approval Date
Feb 20, 2021
NMPA

Azlocillin Sodium for Injection

Product Name
注射用阿洛西林钠
Approval Number
国药准字H20053228
Approval Date
Feb 20, 2021
NMPA

Ticarcillin Disodium and Clavulanate Potassium for Injection

Product Name
注射用替卡西林钠克拉维酸钾
Approval Number
国药准字H20059792
Approval Date
Feb 20, 2021
NMPA

Mezlocillin Sodium for Injection

Product Name
注射用美洛西林钠
Approval Number
国药准字H20064204
Approval Date
Feb 20, 2021
NMPA

Azlocillin Sodium for Injection

Product Name
注射用阿洛西林钠
Approval Number
国药准字H20064923
Approval Date
Feb 20, 2021
NMPA

Azlocillin Sodium for Injection

Product Name
注射用阿洛西林钠
Approval Number
国药准字H20053230
Approval Date
Feb 20, 2021
NMPA

Ampicillin Sodium and Cloxacillin Sodium for Injection

Product Name
注射用氨苄西林钠氯唑西林钠
Approval Number
国药准字H20053268
Approval Date
Feb 20, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.